157 related articles for article (PubMed ID: 17043968)
61. Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis.
Wang JD; Dong YC; Sheng Z; Ma HH; Li GL; Wang XL; Lu GM; Sugimura H; Jin J; Zhou XJ
Oncology; 2007; 73(3-4):238-45. PubMed ID: 18424888
[TBL] [Abstract][Full Text] [Related]
62. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
[TBL] [Abstract][Full Text] [Related]
63. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
64. [Relationship between urokinase-type plasminogen activator expression and peritoneal metastatic potency in different gastric cancer cell lines].
Ding YC; Zhu ZG; Liu BY; Ji YB; Chen XH; Zhang Y; Yu YY; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):249-51. PubMed ID: 16167240
[TBL] [Abstract][Full Text] [Related]
65. Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Aihara R; Mochiki E; Nakabayashi T; Akazawa K; Asao T; Kuwano H
Br J Surg; 2005 Apr; 92(4):454-62. PubMed ID: 15609380
[TBL] [Abstract][Full Text] [Related]
66. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma].
He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404
[TBL] [Abstract][Full Text] [Related]
67. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
68. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
He Q; Chen J; Lin HL; Hu PJ; Chen MH
Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
[TBL] [Abstract][Full Text] [Related]
69. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
[TBL] [Abstract][Full Text] [Related]
70. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
[TBL] [Abstract][Full Text] [Related]
71. [Expression of ezrin in human lung carcinoma and its clinicopathologic significance.].
Lan L; Sun T; Liu D; Pang J; Yang L; Yang C; Xiong D
Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):67-73. PubMed ID: 20727270
[TBL] [Abstract][Full Text] [Related]
72. Ezrin is associated with gastric cancer progression and prognosis.
Li L; Wang YY; Zhao ZS; Ma J
Pathol Oncol Res; 2011 Dec; 17(4):909-15. PubMed ID: 21717114
[TBL] [Abstract][Full Text] [Related]
73. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
74. [Expression and clinical significance of cancer-related gene MPS-1 in gastric cancer].
Wang YW; Zhu ZG; Liu BY; Gu QL; Li JF; Qu Y; Chen XH; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):503-6. PubMed ID: 16299651
[TBL] [Abstract][Full Text] [Related]
75. Knockdown of ezrin via RNA interference suppresses Helicobacter pylori-enhanced invasion of gastric cancer cells.
Fan LL; Chen DF; Lan CH; Liu KY; Fang DC
Cancer Biol Ther; 2011 Apr; 11(8):746-52. PubMed ID: 21282970
[TBL] [Abstract][Full Text] [Related]
76. Clinical implications of Ezrin and CD44 co‑expression in breast cancer.
Ma L; Jiang T
Oncol Rep; 2013 Oct; 30(4):1899-905. PubMed ID: 23900701
[TBL] [Abstract][Full Text] [Related]
77. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
[TBL] [Abstract][Full Text] [Related]
78. miR-183 inhibits invasion of gastric cancer by targeting Ezrin.
Cao LL; Xie JW; Lin Y; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Chen QY; Huang CM
Int J Clin Exp Pathol; 2014; 7(9):5582-94. PubMed ID: 25337200
[TBL] [Abstract][Full Text] [Related]
79. Immunohistochemical distribution of heat shock protein 47 (HSP47) in scirrhous carcinoma of the stomach.
Hirai K; Kikuchi S; Kurita A; Ohashi S; Adachi E; Matsuoka Y; Nagata K; Watanabe M
Anticancer Res; 2006; 26(1A):71-8. PubMed ID: 16475681
[TBL] [Abstract][Full Text] [Related]
80. Berberine inhibits the invasion and metastasis of nasopharyngeal carcinoma cells through Ezrin phosphorylation.
Huang D; Wang W; Feng Z; Wang L; Chen Y; Xie C; Meng J; Tang F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):616-23. PubMed ID: 21873785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
